Hutch News

Hutch News

Stories tagged 'gene editing'

Gene editing shows promise for sickle cell and related disorders

Preclinical results offer new hope in group of dangerous inborn diseases

May 23, 2018 | By Susan Keown / Fred Hutch News Service

New research, not yet in humans, suggests that a novel gene-editing strategy holds promise for people with sickle cell disease and other serious inborn disorders of hemoglobin.

View story >


Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


New nanoparticles make targeted, temporary gene therapy possible

‘Hit-and-run’ technology could improve immunotherapy and HIV cure research

Aug. 30, 2017 | By Sabrina Richards / Fred Hutch News Service

'Hit-and-run' technology could improve immunotherapy and HIV cure research

View story >


Looking for ‘a multitude of ways to cure HIV’

HIV researchers draw hope from cancer immunotherapies — and inspiration from Timothy Ray Brown

Aug. 21, 2017 | By Mary Engel / Fred Hutch News Service

HIV researchers draw hope from advances in cancer immunotherapies — and inspiration from Timothy Ray Brown's now 10-year-old cure.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 2, 2017

Novel gene therapy for sickle cell disease and related disorders on the horizon; immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care; Dr. Cara McDermott receives AcademyHealth new investigator award; and study documents sperm changes years after chemotherapy.

View story >


Gene therapy goes global: Portable device could make future cancer, HIV cures affordable

Portable 'gene therapy in a box' could make future cancer, HIV cures affordable in developing countries

Oct. 20, 2016 | By Mary Engel / Fred Hutch News Service

"Gene therapy in a box," developed by Fred Hutch's Dr. Jennifer Adair, suggests a solution to one of the most vexing challenges of gene therapy: How to make these emerging, high-tech treatments accessible and affordable beyond a handful of specialized research centers to clinics worldwide.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.